ScholarLens Back to search
2006•Zhongguo quanke yixueRequires access

A New Reuptake Inhibitor of the Serotonin and Norepinephrine-Duloxetine

Shi Ai-xi

Open publisher page 0 citations

Abstract

Duloxetine is a selective reuptake inhibitor of the serotonin and norepinephrine.It is approved by the Food and Drug Administration (FDA) in the United States for the treatment of both major depressive disorder (MDD) and diabetic peripheral neuropathy (DPNP).In Europe,duloxetine is also labeled for stress urinary incontinence (SUI).The pharmacological effect and clinical evaluation of Duloxetine for the treatment of MDD are summarized in this paper.

About this research paper

What this paper is about

Duloxetine is a selective reuptake inhibitor of the serotonin and norepinephrine.It is approved by the Food and Drug Administration (FDA) in the United States for the treatment of both major depressive disorder (MDD) and diabetic peripheral neuropathy (DPNP).In Europe,duloxetine is also labeled for stress urinary incontinence (SUI).The pharmacological effect and clinical evaluation of Duloxetine for the treatment of MDD are summarized in this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Duloxetine is a selective reuptake inhibitor of the serotonin and norepinephrine.It is approved by the Food and Drug Administration (FDA) in the United States for the treatment of both major depressive disorder (MDD) and diabetic peripheral neuropathy (DPNP).In Europe,duloxetine is also labeled for stress urinary incontinence (SUI).The pharmacological effect and clinical evaluation of Duloxetine for the treatment of MDD are summarized in this paper.

Key concepts: Duloxetine, Medicine, Reuptake inhibitor, Duloxetine Hydrochloride, Norepinephrine, Serotonin, Serotonin reuptake inhibitor, Major depressive disorder

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A New Reuptake Inhibitor of the Serotonin and Norepinephrine-Duloxetine — Research Paper | ScholarLens